Participants' experiences of being debriefed to placebo allocation in a clinical trial

Qualitative Health Research

Volumn 22, Issue 8, 2012, Pages 1138-1149

  Bishop, Felicity L ^a   Jacobson, Eric E ^b   Shaw, Jessica ^b   Kaptchuk, Ted J ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alternative and complementary; Ethics moral perspectives; Giorgi; Health care; Interviews, semistructured; Phenomenology; Research participation; Research, quantitative

Indexed keywords

PLACEBO;

ACUPUNCTURE; ARTICLE; ATTITUDE TO HEALTH; HUMAN; INTERPERSONAL COMMUNICATION; IRRITABLE COLON; METHODOLOGY; PATIENT EDUCATION; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL SUPPORT;

ACUPUNCTURE THERAPY; COMMUNICATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IRRITABLE BOWEL SYNDROME; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; PLACEBOS; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIAL SUPPORT;

EID: 84863658513     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732312448544     Document Type: Article

References (41)

1. Appelbaum P. S., Roth L. H., Lidz C. W., Benson P., Winslade W.. False hopes and best data-Consent to research and the therapeutic misconception. Hastings Center Report. 1987 ; 17 (2). 20-24
2. Ashworth A., Ashworth P.. The lifeworld as phenomenon and as research heuristic, exemplified by a study of the lifeworld of a person suffering Alzheimer's disease. Journal of Phenomenological Psychology. 2003 ; 34 (2). 179-205
3. Ashworth P.. An approach to phenomenological psychology: The contingencies of the lifeworld. Journal of Phenomenological Psychology. 2003 ; 34 (2). 145-156
4. Ashworth P., Freewood M., Macdonald R.. The student lifeworld and the meanings of plagiarism. Journal of Phenomenological Psychology. 2003 ; 34 (2). 257-278
5. Avins A., Bent S., Padula A., Staccone S., Badua E., Goldberg H.. Initial experience with a group presentation of study results to research participants. Trials. 2008 ; 9 (1). 16
6. Beskow L. M., Burke W., Merz J. F., Barr P. A., Terry S., Penchaszadeh V. B.,... Khoury M. J.. Informed consent for population-based research involving genetics. Journal of the American Medical Association. 2001 ; 286 (18). 2315-2321
7. Buchwald H., Fitch L. L., Matts J. P., Johnson J. W., Hansen B. J., Stuenkel M. R., Brooks H. B.. Perception of quality of life before and after disclosure of trial results: A report from the Program on the Surgical Control of the Hyperlipidemias (POSCH). Controlled Clinical Trials. 1993 ; 14 (6). 500-510
8. Bylund C. L., Gueguen J. A., Sabee C. M., Imes R. S., Li Y., Aldridge Sanford A.. Provider-patient dialogue about Internet health information: An exploration of strategies to improve the provider-patient relationship. Patient Education and Counseling. 2007 ; 66: 346-352
9. Chung S. K., Price D. D., Verne G. N., Robinson M. E.. Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding. Pain. 2007 ; 132 (3). 281-288
10. Department of Health. (2005). Research governance framework for health and social care (2nd ed.). London: Department of Health. Retrieved from http://www.dh.gov.uk
11. Di Blasi Z., Crawford F., Bradley C., Kleijnen J.. Reactions to treatment debriefing among the participants of a placebo controlled trial. BMC Health Services Research. 2005 ; 5: 30
12. Di BlasiZ.KaptchukT. J.WeinmanJ.KleijnenJ. (2002). Informing participants of allocation to placebo at trial closure: Postal survey. British Medical Journal, 325(7376), 1329. Retrieved from http://www.bmj.com/cgi/content/ abstract/325/7376/1329
13. Dinnett E. M., Mungall M. M., Kent J. A., Ronald E. S., McIntyre K. E., Anderson E., Gaw A.. Unblinding of trial participants to their treatment allocation: Lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Clinical Trials. 2005 ; 2 (3). 254-259
14. Dixon-Woods M., Jackson C., Windridge K. C., Kenyon S.. Receiving a summary of the results of a trial: Qualitative study of participants' views. British Medical Journal. 2006 ; 332 (7535). 206-209
15. Evans B. W., Clark W. K., Moore D. J., Whorwell P. J.. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database of Systematic Reviews. 2007 ; 4:
16. Fergusson D., Glass K. C., Waring D., Shapiro S.. Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. British Medical Journal. 2004 ; 328 (7437). 432
17. Gearing R. E.. Bracketing in research: A typology. Qualitative Health Research. 2004 ; 14: 1429-1452
18. Giorgi A. Phenomenology and psychological research. Giorgi A., ed. Pittsburgh, PA: Duquesne University Press ; 1985: 8-22.
19. Goetz C. G., Janko K., Blasucci L., Jaglin J. A.. Impact of placebo assignment in clinical trials of Parkinson's disease. Movement Disorders. 2003 ; 18 (10). 1146-1149
20. Goffman E. Interaction ritual: Essays on face-to-face behavior. Garden City, NY: Anchor Books ; 1967:
21. Håkanson C., Sahlberg-Blom E., Ternestedt B.-M.. Being in the patient position: Experiences of health care among people with irritable bowel syndrome. Qualitative Health Research. 2010 ; 20: 1116-1127
22. Hochman M., McCormick D.. Characteristics of published comparative effectiveness studies of medications. Journal of the American Medical Association. 2010 ; 303 (10). 951-958
23. Kaptchuk T. J., Kelley J. M., Conboy L. A., Davis R. B., Kerr C. E., Jacobsen E. E.,... Lembo A. J.. Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome. British Medical Journal. 2008 ; 336: 999-1003
24. Kaptchuk T. J., Shaw J., Kerr C. E., Conboy L. A., Kelley J. M., Csordas T. J.,... Jacobsen E. E.. "Maybe I made up the whole thing": Placebos and patients' experiences in a randomized controlled trial. Culture Medicine and Psychiatry. 2009 ; 33: 382-411
25. Lacy B. E., Weiser K., Noddin L., Robertson D. J., Crowell M. D., Parratt-Engstrom C., Grau M. V.. Irritable bowel syndrome: Patients' attitudes, concerns and level of knowledge. Alimentary Pharmacology & Therapeutics. 2007 ; 25 (11). 1329-1341
26. Langdridge D. Phenomenological psychology. Theory, research and method. Harlow, UK: Pearson Prentice Hall ; 2007:
27. Leventhal H. A., Brissette I., Leventhal E. A. The self-regulation of health and illness behaviour. Cameron L. D. Leventhal H., ed. London: Routledge ; 2003: 42-65.
28. MillerF. G.KaptchukT. J. (2004). Sham procedures and the ethics of clinical trials. Journal of the Royal Society of Medicine, 97(12), 576-578. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079669/pdf/00970576. pdf
29. Naldi L., Svensson A., Zenoni D., Diepgen T., Elsner P., Grob J.-J.,... Williams H.. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: Update of the EDEN Psoriasis Survey 2001-2006. British Journal of Dermatology. 2010 ; 162 (2). 384-389
30. Pollock K.. Maintaining face in the presentation of depression: Constraining the therapeutic potential of the consultation. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine. 2007 ; 11 (2). 163-180
31. Potter J. Representing reality: Discourse, rhetoric and social construction. London: Sage ; 1996:
32. Richards M. P. M., Ponder M., Pharoah P., Everest S., Mackay J.. Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. Journal of Medical Ethics. 2003 ; 29 (2). 93-96
33. Riedl A., Maass J., Fliege H., Stengel A., Schmidtmann M., Klapp B. F., Mönnikes H.. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome. Journal of Psychosomatic Research. 2009 ; 67 (5). 449-455
34. Rutter C. L., Rutter D. R.. Illness representation, coping and outcome in irritable bowel syndrome (IBS). British Journal of Health Psychology. 2002 ; 7: 377-391
35. Rutter C. L., Rutter D. R.. Longitudinal analysis of the illness representation model in patients with irritable bowel syndrome (IBS). Journal of Health Psychology. 2007 ; 12 (1). 141-148
36. Sandler A., Glesne C., Geller G.. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD. Child: Care, Health and Development. 2008 ; 34 (1). 111-120
37. Shalowitz D. I., Miller F. G.. Disclosing individual results of clinical research: Implications of respect for participants. Journal of the American Medical Association. 2005 ; 294 (6). 737-740
38. Shalowitz D. I., Miller F. G.. Communicating the results of clinical research to participants: Attitudes, practices, and future directions. PLoS Medicine. 2008 ; 5 (5). e91
39. Stang A., Hense H.-W., Jöckel K.-H., Turner E. H., Tramèr M. R.. Is it always unethical to use a placebo in a clinical trial?. PLoS Medicine. 2005 ; 2 ( 3 ):
40. Streitberger K., Kleinhenz J.. Introducing a placebo needle into acupuncture research. Lancet. 1998 ; 352 (9125). 364-365
41. Yin R. K. Applied social research methods series: Vol. 5. Case study research. 2009 ). Applied social research methods series: Vol. 5. Case study research (4th ed.). Thousand Oaks, CA: Sage. Thousand Oaks, CA: Sage ; 2009: